Racial disparities in clinical trials of biologic treatments for psoriatic arthritis

J Am Acad Dermatol. 2022 Oct;87(4):910-912. doi: 10.1016/j.jaad.2021.08.038. Epub 2021 Aug 28.

Authors

Samantha Shwe¹, Cristina Nguyen², Tina Bhutani³

Affiliations

¹ Department of Dermatology, University of California, Irvine, Irvine, California. Electronic address: sshwe@uci.edu.
² Department of Dermatology, University of California, Irvine, Irvine, California.
³ Department of Dermatology, University of California, San Francisco, San Francisco, California.

PMID: 34464628
DOI: 10.1016/j.jaad.2021.08.038

No abstract available

Keywords: biologic; clinical trials; general dermatology; psoriatic arthritis; racial disparities.

MeSH terms

Antirheumatic Agents / therapeutic use
Arthritis, Psoriatic* / drug therapy
Biological Products / therapeutic use
Clinical Trials as Topic*
Healthcare Disparities* / ethnology
Humans
Racial Groups*

Substances

Antirheumatic Agents
Biological Products